Nov 8 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA REPORTS THIRD QUARTER FINANCIAL RESULTS, CLINICAL HIGHLIGHTS AND CORPORATE DEVELOPMENT
* AURINIA PHARMACEUTICALS INC - RICHARD M. GLICKMAN, COMPANY'S CHAIRMAN AND CHIEF EXECUTIVE OFFICER, INTENDS TO RETIRE
* AURINIA PHARMACEUTICALS - GLICKMAN TO RETIRE AS CEO ONCE A REPLACEMENT IS IDENTIFIED AND APPOINTED
* AURINIA PHARMACEUTICALS INC - AT SEPTEMBER 30, 2018, WE HAD CASH, CASH EQUIVALENTS AND SHORT TERM INVESTMENTS OF $138.9 MILLION
* AURINIA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.21